BRIDGEWAY CAPITAL MANAGEMENT, LLC - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is and the CUSIP is 67424L209. A total of 13 filers reported holding OBALON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$93,000
+86.0%
33,0000.0%0.00%
+100.0%
Q4 2020$50,000
+66.7%
33,0000.0%0.00%0.0%
Q3 2020$30,000
+30.4%
33,0000.0%0.00%
Q2 2020$23,000
-4.2%
33,0000.0%0.00%
-100.0%
Q1 2020$24,00033,0000.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 380,224$268,0000.22%
Cerity Partners LLC 155,000$109,0000.01%
WELLS FARGO & COMPANY/MN 45$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 332$00.00%
GEODE CAPITAL MANAGEMENT, LLC 11,709$8,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,562$1,0000.00%
Citadel Advisors 38,296$27,0000.00%
ROYAL BANK OF CANADA 50$00.00%
View complete list of OBALON THERAPEUTICS INC shareholders